US gene team gets $1.3m in grants
This article was originally published in Clinica
The San Antonio, Texas-based Southwest Foundation for Biomedical Research (SFBR) has received two grants totalling $1.3m for its research into genetic diseases.
You may also be interested in...
Series C investment of an undisclosed amount announced in early May follows $20m funding for the Los Angeles company from Volition Capital and angel investors.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
La Jolla’s formulation appears blocked by Amivas’ seven-year orphan exclusivity, and the company also will miss out on chance for a tropical disease priority review voucher; Amivas worked with the US Army to bring the severe malaria treatment through final stages of development and regulatory review.